Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation

Haematologica

Volumn 95, Issue 10, 2010, Pages 1633-1641

  Lulli, Valentina ^a   Romania, Paolo ^a   Riccioni, Roberta ^a   Boe, Alessandra ^a   Lo Coco, Francesco ^b,c   Testa, Ugo ^a   Marziali, Giovanna ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Granulocytic differentiation; Hematopoiesis; Transcription factors

Indexed keywords

CD34 ANTIGEN; DIMETHYL SULFOXIDE; DNA; PROTEIN P51; RETINOIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DNA BINDING; EXON; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GENETIC VARIABILITY; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; NEUTROPHIL COUNT; POSTTRANSCRIPTIONAL GENE SILENCING; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE SILENCING; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; LEUKEMIA; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, SMALL INTERFERING;

EID: 77957777267     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.023267     Document Type: Article

References (38)

1. Watson DK, Seth A. Ets Gene Family. Oncogene Reviews 2000; 19 (55) review issue 5, Macmillan Publishers Ltd.
2. Dittmer J. The biology of Ets-1 proto-oncogene. Mol Cancer. 2003;2:29-49.
3. Koizumi S, Fisher RJ, Fujiwara S, Jorcyk C, Bhat NK, Seth A, et al. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene. 1990;5(5):675-681.
4. Skalicky JJ, Donaldson LW, Petersen JM, Graves BJ, McIntosh LP. Structural coupling of the inhibitory regione flanking the Ets domain of murine Ets-1. Protein Sci. 1996; 5(2):296-309.
5. Garvie CW, Pufall MA, Graves BJ, Wolberger C. Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships. J Biol Chem. 2002; 277(47):45529-45536.
6. Foulds CE, Nelson ML, Blaszczak AG, Graves BJ. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol. 2004; 24(24):10954-10964.
7. Seidel JJ, Graves BJ. An ERK2 docking site in the pointed domain distinguishes a subset of Ets transcription factors. Genes Dev. 2002;16(1):127-137.
8. Cowley DO, Graves BJ. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev. 2000;14(3):366-376.
9. Pufall MA, Lee GM, Nelson ML, Kang HS, Velyvis A, Kay LE, et al. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science. 2005; 309(5731):142-145.
10. Fleischman LF, Holtzclaw L, Russell JT, Mavrothalassitis G, Fisher RJ. Ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol. 1995;15(2): 925-931.
11. Oikawa T. ETS transcription factors: possible targets for cancer therapy. Cancer Sci. 2004;95(8):626-633.
12. Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006;24(24): 3887-3894.
13. Tyybäkinoja A, Saarinen-Pihkala U, Elonen E, Knuutila S. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer. 2006;45(3): 257-264.
14. Mrózek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol. 2008;35(4):365-377.
15. Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, et al. Increased T-cell apoptosis and terminal Bcell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 1995;377(6550):635-638.
16. Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 1995;377(6550):639-642.
17. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9(4):555-563.
18. Jackers P, Szalai G, Moussa O, Watson DK. Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem. 2004;279(50):52183-52190.
19. Lulli V, Romania P, Morsilli O, Gabbianelli M, Pagliuca A, Mazzeo S, et al. Ets-1 blocks erythroid and promotes megakaryocytic differentiation through modulation of GATA-2 expression. Cell Death Differ. 2006;13(7):1064-1074.
20. McNagny KM, Sieweke M, Doderlein G, Graf T, Nerlov C. Regulation of eosinophil specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J. 1998; 17(13):3669-3680.
21. Khanna-Gupta A, Kolibaba K, Zibello TA, Berliner N. NB4 cells show bilineage potential and an aberrant pattern of neuthrophil secondare granule protein gene expression. Blood. 1994;84(1):294-302.
22. Breitman TR, He RY. Combinations of retinoic acid with either sodium butyrate, dimethil sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Cancer Res. 1990;50(19): 6268-6273.
23. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA. 1994;91(18):8428-8432.
24. Robertson KA, Emami B, Collins SJ. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood. 1992; 80(8):1885-1889.
25. Nakano T, Abe M, Tanaka K, Shineha R, Satomi S, Sato Y. Angiogenesis Inhibition by transdominant mutant Ets-1. J Cell Physiol. 2000;184(2):255-262.
26. Bahnson AB, Dunigan JT, Baysal BE, Mohney T, Atchison RW, Nimgaonkar MT, et al. Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods. 1995;54(2-3):131-143.
27. Gabbianelli M, Testa U, Massa A, Pelosi E, Sposi NM, Riccioni R, et al. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood. 2000;95(11):3555-3561.
28. Grenningloh R, Miaw SC, Moisan J, Graves BJ, Ho IC. Role of Ets-1 phosphorylation in the effector function of Th cells. Eur J Immunol. 2008;38(6):1700-1705.
29. Felli N, Pedini F, Romania P, Biffoni M, Morsilli O, Castelli G, et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica. 2009;94(4):479-486.
30. Lefter LP, Dima S, Sunamura M, Furukawa T, Sato Y, Abe M, et al. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer. Cancer Gene Ther. 2009;16(2):137-148.
31. Launay S, Giannì M, Diomede L, Machesky LM, Enouf J, Papp B. Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calciumdependent signaling. Blood. 2003;101(8): 3220-3228.
32. Launay S, Giannì M, Kovàcs T, Bredoux R, Bruel A, Gélébart P, et al. Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood. 1999;93(12):4395-4405.
33. Si J, Collins SJ. Activated Ca2+/calmodulindependent protein kinase II gamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res. 2008;68(10): 3733-3742.
34. So EN, Crowe DL. Characterization of a retinoic acid responsive element in the human ets-1 promoter. IUBMB Life. 2000;50(6):365-370.
35. Fatica A, Rosa A, Ballarino M, De Marchis ML, Rasmussen KD, Bozzoni I. Role of microRNAs in myeloid differentiation. Biochem Soc Trans. 2008;36(Pt 6):1201-1205.
36. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-838.
37. Katayama S, Nakayama T, Ito M, Naito S, Sekine I. Expression of the ets-1 protooncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol Histopathol. 2005;20(1):119-126.
38. Nakayama T, Ito M, Ohtsuru A, Naito S, Sekine I. Expression of the ets-1 protooncogene in human colorectal carcinoma. Mod Pathol 2001;14(5):415-422.